| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,197 |
5,991 |
$742K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,103 |
989 |
$111K |
| 99490 |
Ccm add 20min |
2,545 |
2,537 |
$100K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,384 |
2,211 |
$69K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
624 |
624 |
$53K |
| 99487 |
Ccm add 20min |
596 |
595 |
$50K |
| 99426 |
|
1,278 |
1,275 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,357 |
2,253 |
$32K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
321 |
320 |
$30K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
255 |
254 |
$25K |
| 99497 |
|
521 |
520 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,654 |
1,564 |
$23K |
| 99439 |
|
704 |
700 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
504 |
500 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,940 |
1,553 |
$17K |
| 99385 |
|
134 |
133 |
$15K |
| 99386 |
|
83 |
83 |
$11K |
| 96156 |
|
207 |
206 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
1,322 |
1,283 |
$6K |
| 99407 |
|
417 |
343 |
$6K |
| 20553 |
|
115 |
115 |
$4K |
| 99442 |
|
54 |
43 |
$4K |
| 99406 |
|
411 |
400 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
29 |
29 |
$3K |
| 96127 |
|
920 |
885 |
$3K |
| 29530 |
|
124 |
120 |
$2K |
| 81003 |
|
1,108 |
1,032 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
341 |
321 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,059 |
891 |
$2K |
| 29540 |
|
93 |
91 |
$1K |
| 80305 |
|
132 |
130 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
517 |
489 |
$725.74 |
| 90688 |
|
30 |
30 |
$590.07 |
| 99473 |
|
74 |
72 |
$585.04 |
| 29125 |
|
13 |
13 |
$533.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
32 |
31 |
$520.35 |
| 69209 |
|
31 |
31 |
$382.01 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16 |
12 |
$354.68 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
18 |
18 |
$341.94 |
| 29130 |
|
12 |
12 |
$326.38 |
| 90658 |
|
27 |
27 |
$314.80 |
| 93000 |
|
34 |
34 |
$283.48 |
| 82962 |
|
59 |
58 |
$154.24 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
32 |
32 |
$146.84 |
| 81025 |
|
19 |
15 |
$137.75 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16 |
16 |
$118.89 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
388 |
366 |
$96.33 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
84 |
79 |
$56.92 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
18 |
18 |
$48.15 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
153 |
143 |
$2.94 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
28 |
25 |
$2.80 |
| 3074F |
|
789 |
777 |
$1.44 |
| 3078F |
|
665 |
656 |
$1.19 |
| S9449 |
Weight management classes, non-physician provider, per session |
174 |
166 |
$0.47 |
| 3079F |
|
196 |
193 |
$0.34 |
| 1034F |
|
186 |
185 |
$0.28 |
| S9452 |
Nutrition classes, non-physician provider, per session |
115 |
114 |
$0.26 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
418 |
408 |
$0.23 |
| 3075F |
|
127 |
125 |
$0.23 |
| 3048F |
|
137 |
135 |
$0.23 |
| S9451 |
Exercise classes, non-physician provider, per session |
54 |
47 |
$0.16 |
| 3080F |
|
61 |
60 |
$0.08 |
| 3049F |
|
32 |
32 |
$0.06 |
| 3077F |
|
31 |
31 |
$0.04 |
| 3050F |
|
12 |
12 |
$0.03 |
| 3044F |
|
480 |
465 |
$0.03 |
| 1160F |
|
191 |
191 |
$0.01 |
| 1159F |
|
230 |
219 |
$0.01 |
| 3725F |
|
1,002 |
991 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
291 |
288 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
503 |
393 |
$0.00 |
| 3288F |
|
33 |
33 |
$0.00 |
| 2000F |
|
955 |
943 |
$0.00 |
| 1125F |
|
32 |
32 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
167 |
160 |
$0.00 |
| 1036F |
|
309 |
308 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
395 |
392 |
$0.00 |
| 97802 |
|
136 |
125 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
53 |
48 |
$0.00 |
| 1170F |
|
45 |
45 |
$0.00 |